{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:19:18Z","timestamp":1792592358569,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1136\/ard.2010.142109","type":"journal-article","created":{"date-parts":[[2010,11,19]],"date-time":"2010-11-19T18:21:24Z","timestamp":1290190884000},"page":"2062-2066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Prevention of autoimmune rheumatic disease: state of the art and future perspectives"],"prefix":"10.1016","volume":"69","author":[{"given":"Lars","family":"Klareskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.142109_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2007.10.002","article-title":"Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis","volume":"38","author":"Satpute","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib2","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1073\/pnas.0813037106","article-title":"Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7","volume":"106","author":"Hayashi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2010.142109_bib3","doi-asserted-by":"crossref","first-page":"19875","DOI":"10.1073\/pnas.0805198105","article-title":"Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis","volume":"105","author":"Choi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2010.142109_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2010.142109_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib6","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/498651","article-title":"Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI 4","volume":"77","author":"Plenge","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2010.142109_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1086\/516736","article-title":"Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis","volume":"80","author":"Kallberg","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2010.142109_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/ar2384","article-title":"Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets","volume":"10","author":"van der Helm-van Mil","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.142109_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.24135","article-title":"Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region","volume":"60","author":"Ding","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib11","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib12","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","article-title":"Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease","volume":"58","author":"Ioan-Facsinay","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib13","doi-asserted-by":"crossref","first-page":"R458","DOI":"10.1186\/ar1697","article-title":"Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity","volume":"7","author":"Lundberg","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/ard.2010.142109_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2010.142109_bib15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20072051","article-title":"Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice","volume":"205","author":"Hill","year":"2008","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.142109_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1084\/jem.20081862","article-title":"Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis","volume":"206","author":"Uysal","year":"2009","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.142109_bib17","first-page":"734","article-title":"Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA","volume":"34","author":"Yu","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.142109_bib18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2010.142109_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00281-006-0037-0","article-title":"Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies","volume":"28","author":"Baudino","year":"2006","journal-title":"Springer Semin Immunopathol"},{"key":"10.1136\/ard.2010.142109_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/art.20862","article-title":"Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential","volume":"52","author":"Zhao","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaut.2003.11.004","article-title":"Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block","volume":"22","author":"Salomonsson","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2010.142109_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20041859","article-title":"Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block","volume":"201","author":"Salomonsson","year":"2005","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.142109_bib23","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.1001396","article-title":"Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block","volume":"185","author":"Strandberg","year":"2010","journal-title":"J Immunol"},{"key":"10.1136\/ard.2010.142109_bib24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib25","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","article-title":"Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis","volume":"62","author":"Kokkonen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib27","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.11269","article-title":"Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol","volume":"48","author":"Quinn","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib28","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/art.20049","article-title":"Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis","volume":"50","author":"Costenbader","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib30","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1002\/art.22210","article-title":"Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women","volume":"54","author":"Finckh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.142109_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/ard.2005.039438","article-title":"Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus","volume":"65","author":"Freemer","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib32","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/rheumatology\/keq214","article-title":"Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents","volume":"49","author":"Cooper","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.142109_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2010.07.005","article-title":"Drug-induced lupus: an update","author":"Katz","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard.2010.142109_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","article-title":"Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour","volume":"227","author":"R\u00f6nnblom","year":"1990","journal-title":"J Intern Med"},{"key":"10.1136\/ard.2010.142109_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1471-4906(01)01955-X","article-title":"An etiopathogenic role for the type I IFN system in SLE","volume":"22","author":"R\u00f6nnblom","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1136\/ard.2010.142109_bib36","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2010.142109_bib37","first-page":"1830","article-title":"Smoking and risk of rheumatoid arthritis","volume":"20","author":"Heli\u00f6vaara","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.142109_bib38","doi-asserted-by":"crossref","unstructured":"K\u00e4llberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis. Estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2010. (In press).","DOI":"10.1136\/ard.2009.120899"},{"key":"10.1136\/ard.2010.142109_bib39","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/ard.2009.114694","article-title":"Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis","volume":"69","author":"Stolt","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2007.086314","article-title":"Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies","volume":"68","author":"K\u00e4llberg","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib41","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/rheumatology\/keq202","article-title":"Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis","volume":"49","author":"Maxwell","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.142109_bib42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.0608620104","article-title":"Ethanol prevents development of destructive arthritis","volume":"104","author":"Jonsson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2010.142109_bib43","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1136\/ard.2010.129908","article-title":"Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"69","author":"Bengtsson","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2008.105767","article-title":"Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/ard.2009.119149","article-title":"Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial","volume":"69","author":"Verstappen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ard.2009.122473","article-title":"The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis","volume":"69","author":"Machold","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib47","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/ard.2007.084269","article-title":"Does the use of tumour necrosis factor antagonist therapy in poor prognosis, undifferentiated arthritis prevent progression to rheumatoid arthritis?","volume":"67","author":"Saleem","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/ard.2009.119016","article-title":"Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)","volume":"69","author":"Emery","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.rdc.2010.02.001","article-title":"Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation","volume":"36","author":"Deane","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.2010.142109_bib50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2249.2008.03732.x","article-title":"Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block","volume":"154","author":"Strandberg","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2010.142109_bib51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-3083.2010.02446.x","article-title":"Immunological contribution to the pathogenesis of congenital heart block","volume":"72","author":"Wahren-Herlenius","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.2010.142109_bib52","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/ard.2009.123828","article-title":"Genetic variants in the prediction of rheumatoid arthritis","volume":"69","author":"van der Helm-van Mil","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.142109_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1058","article-title":"Positional identification of Ncf1 as a gene that regulates arthritis severity in rats","volume":"33","author":"Olofsson","year":"2003","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2010.142109_bib54","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1371\/journal.pmed.0030348","article-title":"A new arthritis therapy with oxidative burst inducers","volume":"3","author":"Hultqvist","year":"2006","journal-title":"PLoS Med"},{"key":"10.1136\/ard.2010.142109_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/428480","article-title":"Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus","volume":"76","author":"Sigurdsson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2010.142109_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ng1782","article-title":"A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus","volume":"38","author":"Graham","year":"2006","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2010.142109_bib57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364408","article-title":"High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus","volume":"8","author":"Niewold","year":"2007","journal-title":"Genes Immun"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724147528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724147528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.142109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T11:30:02Z","timestamp":1736076602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724147528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0003496724147528"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.142109","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of autoimmune rheumatic disease: state of the art and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.142109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}